Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djae208 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Yin Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Genetic Predisposition to Disease, Age of Onset. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mayer Fund Doctoral Scholarship, NCI NIH HHS, British Heart Foundation.
Abstract (Originalsprache)
Background
Early-onset cancer (diagnosed under age 50) generally manifests as an aggressive disease phenotype. The association between healthy lifestyle and early-onset cancer and whether it varies by common genetic variants remains unclear.
Methods
We analyzed a prospective cohort of 66 308 participants who were under age 50 and free of cancer at baseline in the UK Biobank. Using Cox regression, we estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for early-onset total and breast cancer based on sex-specific composite total cancer polygenic risk scores (PRSs), a breast cancer-specific PRS, and sex-specific health-associated lifestyle scores (HLSs).
Results
In multivariable-adjusted analyses with 2-year latency, higher genetic risk (highest vs lowest tertile of PRS) was associated with significantly increased risks of early-onset total cancer in females (HR, 95% CI = 1.83, 1.49 to 2.26) and males (2.03, 1.51 to 2.73) as well as early-onset breast cancer in females (3.06, 2.20 to 4.26). An unfavorable lifestyle (highest vs lowest category of HLS) was associated with higher risk of total cancer and breast cancer in females across genetic risk categories; the association with total cancer and breast cancer was stronger in the highest genetic risk category than the lowest: HRs (95% CIs) were 1.55 (1.12 to 2.14) and 1.69 (1.11 to 2.57) in the highest genetic risk category and 1.03 (0.64 to 1.67) and 0.81 (0.36 to 1.85) in the lowest.
Conclusions
Genetic and lifestyle factors were independently associated with early-onset total and breast cancer risk. Individuals with a high genetic risk may benefit more from adopting a healthy lifestyle in preventing early-onset cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- Department of Epidemiology, University of Washington, Seattle, WA, USA.
- Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
ORCID-Profile: Yuxi Liu
Förderung
- Mayer Fund Doctoral Scholarship
- NCI NIH HHS
- British Heart Foundation
- Northwest Regional Development Agency
- Irene M. & Fredrick J. Stare Nutrition Education Fund Doctoral Scholarship
- NIH HHS
- Department of Health, Scottish Government
- Medical Research Council
Zitieren
APA
Zhang, Y., Lindström, S., Kraft, P., & Liu, Y. (2025). Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae208
Vancouver
Zhang Y, Lindström S, Kraft P, Liu Y. Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae208
BibTeX
@article{Zhang2025,
author = {Zhang, Yin and Lindström, Sara and Kraft, Peter and Liu, Yuxi},
title = {Genetic risk, health-associated lifestyle, and risk of early-onset total cancer and breast cancer},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djae208}
}
EUVIMED